# Arcus Biosciences, Inc.: Form 8-K, filed Aug 5, 2021

- Company: [Arcus Biosciences, Inc.](/companies/rcus.md) (CIK 1724521)
- Form: 8-K
- Filed: 2021-08-05
- Accepted by EDGAR: Aug 5, 2021, 16:13 ET
- Period: 2021-08-03
- Accession: 0001564590-21-041591
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1724521/000156459021041591/rcus-8k_20210803.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1724521/000156459021041591/

## Items reported

- Item 2.02: Results of operations
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1724521/000156459021041591/rcus-8k_20210803.htm

Filed Aug 5, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-041591. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.
